高氨血症
高胰岛素血症
医学
低血糖
高胰岛素性低血糖
内科学
谷氨酸脱氢酶
内分泌学
先天性高胰岛素血症
高胰岛素血症
代谢紊乱
儿科
胰岛素
谷氨酸受体
胰岛素抵抗
受体
作者
Christel Tran,Vassiliky Konstantopoulou,Michelle Mecjia,Kusiel Perlman,Saadet Mercimek‐Mahmutoglu,Jonathan B. Kronick
标识
DOI:10.1515/jpem-2014-0441
摘要
BACKGROUND: Hyperinsulinism-hyperammonemia syndrome (HI/HA) is a rare autosomal dominant disorder presenting with hypoglycemia and hyperammonemia. It is caused by activating mutations in the GLUD1 gene. CASE REPORTS: Three patients from two different centers, a 14-month-old female, a 28-year-old female (mother of the first patient) from Toronto and an unrelated 2.5-year-old male from Vienna, presented with multiple episodes of seizures associated with hypoglycemia. RESULTS: All patients had mild to moderate hypoglycemia, inappropriate insulin levels and mild hyperammonemia, thus suggesting a disorder of glutamate dehydrogenase (GDH). Molecular genetic testing of the GLUD1 gene identified heterozygous mutations in all patients (patient 1 and her mother a novel c.1526G>C mutation; patient 3 a known c.809C>G mutation). CONCLUSION: We present three new patients with GDH caused by heterozygous mutation in the GLUD1 gene. Mild hyperammonemia and inappropriately elevated insulin levels should suggest a GLUD1 mutation. Early onset hypoglycemia associated with seizures, and especially a good response to diazoxide treatment, should include this disorder in the differential diagnosis of hyperinsulinemic hypoglycemia.
科研通智能强力驱动
Strongly Powered by AbleSci AI